Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Longitudinal study of neurovascular and glial pathology in the streptozotocin-induced rat model of diabetic retinopathy

Josy Augustine; Rosemary E McDowell; Thomas Friedel; Paul Canning; Alan W Stitt; Tim M Curtis

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1601.

ARVO Annual Meeting Abstract June 2022

2-Hydrazino-4,6-dimethylpyrimidine (2-HDP) as a novel therapeutic for the neurovascular pathology of diabetic retinopathy

Josy Augustine; Evan P Troendle; Thomas Friedel; Eimear M Byrne; Paul Canning; Peter Barabas; Martin B Ulmschneider; Alan W Stitt; Tim M Curtis

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2305.

ARVO Annual Meeting Abstract June 2022

Deletion of Angiotensin II type 2 receptor (AT2) exacerbates retinal neovascularization and hemorrhage in oxygen-induced retinopathy (OIR)

Kevin Harkin; Pietro Bertelli; Hazal Yilmaz; Paul Canning; Ana Rodriguez; Thomas Walther; Alan W Stitt

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2677.

ARVO Annual Meeting Abstract July 2019

Pre-treatment of Endothelial Colony Forming Cells (ECFCs) with a novel anti-oxidant enhances their vasoregenerative potential.

Stuart McKeown; Paul Canning; Caroline Barelle; Fiona Cunningham; Donald McPhail; Andrew J.R Porter; Reinhold J. Medina; Alan W Stitt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1663.

ARVO Annual Meeting Abstract July 2019

Placental growth factor (PlGF) induced signalling regulates barrier properties of the retinal pigment epithelium (RPE)

Fiona Cunningham; Paul Canning; Tine Van Bergen; Jean Feyen; Imre Lengyel; Alan W Stitt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1932.

ARVO Annual Meeting Abstract July 2019

Metabolic plasticity in retinal microvascular endothelial cells exposed to diabetes-related conditions in vitro

David Hughes; Pietro Maria Bertelli; Stuart McKeown; Paul Canning; Elisa Peixoto; Tim M Curtis; Reinhold J. Medina; Alan W Stitt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2705.

ARVO Annual Meeting Abstract July 2019

ARA290 (cibinetide) treatment confers neuroprotective effects in diabetic retinopathy, through modulation of inflammatory mediators.

Paul Canning; Olivia O'Leary; Lynsey-Dawn Allen; Michael Brines; Anthony Cerami; Alan W Stitt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2720.

ARVO Annual Meeting Abstract July 2018

Endothelial colony forming cells modulate angiogenesis by directly integrating with the choroidal vasculature

Stuart McKeown; Paul Canning; Stacy McNutt; Reinhold Medina; Alan W Stitt

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5490.

ARVO Annual Meeting Abstract September 2016

Evidence of Increased Neuronal Glycogen Storage in Short-term Diabetes

Tom A Gardiner; Paul Canning; Nuala Tipping; Alan W Stitt

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2718.

Retinal Cell Biology December 2015

Abnormal Glycogen Storage by Retinal Neurons in Diabetes

PDF

Tom A. Gardiner; Paul Canning; Nuala Tipping; Desmond B. Archer; Alan W. Stitt
TAGS: diabetes mellitus, glycogen, neurons, retina, phosphatidylglycerols
Invest. Ophthalmol. Vis. Sci.. 2015; 56(13):8008-8018. https://doi.org/10.1167/iovs.15-18441

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2013

Lp-PLA 2 is a potential therapeutic target in diabetic macula edema

Paul Canning; Josephine Glenn; Vivien Prise; David Gale; Alan Stitt; Peter Adamson

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4613.

ARVO Annual Meeting Abstract March 2012

Lipoprotein-associated Phospholipase Inhibition Regulates Retinal Vasopermeability During Experimental Diabetes

Alan W. Stitt; Paul Canning; Philip J. Luthert; Josephiine V. Glenn; Lynsey-Dawn Allen; Vivien Prise; Peter S. Adamson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5765.

Advertisement